Antimycobacterial Effect of Selenium Nanoparticles on

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2020 May 20

PMID 32425916

Citations 17

Authors

Hector Estevez

Ainhoa Palacios

David Gil

Juan Anguita

Maria Vallet-Regi

Blanca Gonzalez

Rafael Prados-Rosales

Jose L Luque-Garcia

Affiliations

Soon will be listed here.

Abstract

Tuberculosis (TB) remains the leading cause of death from a single infection agent worldwide. In recent years, the occurrence of TB cases caused by drug-resistant strains has spread, and is expected to continue to grow. Therefore, the development of new alternative treatments to the use of antibiotics is highly important. In that sense, nanotechnology can play a very relevant role, due to the unique characteristics of nanoparticles. In fact, different types of nanoparticles have already been evaluated both as potential bactericides and as efficient drug delivery vehicles. In this work, the use of selenium nanoparticles (SeNPs) has been evaluated to inhibit the growth of two types of mycobacteria: () and (). The results showed that SeNPs are able to inhibit the growth of both types of mycobacteria by damaging their cell envelope integrity. These results open a new opportunity for the use of this type of nanoparticles as antimycobacterial agents by themselves, or for the development of novel nanosystems that combine the action of these nanoparticles with other drugs.

Citing Articles

Preclinical Evaluation of Selene-Ethylenelacticamides in Tuberculosis: Effects Against Active, Dormant, and Resistant and In Vitro Toxicity Investigation.

de Sousa N, de Freitas M, Sidronio M, Souza H, Czeczot A, Perello M Microorganisms. 2025; 13(2).

PMID: 40005762 PMC: 11858155. DOI: 10.3390/microorganisms13020396.

The Immunomodulatory Effects of Selenium: A Journey from the Environment to the Human Immune System.

Sadler R, Mallard B, Shandilya U, Hachemi M, Karrow N Nutrients. 2024; 16(19).

PMID: 39408290 PMC: 11479232. DOI: 10.3390/nu16193324.

Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy.

Liu Y, Wang J, Yang J, Xia J, Yu J, Chen D J Nanobiotechnology. 2024; 22(1):608.

PMID: 39379986 PMC: 11462893. DOI: 10.1186/s12951-024-02875-w.

Role of Divalent Cations in Infections in Host-Pathogen Interaction.

DElia J, Weinrauch L Int J Mol Sci. 2024; 25(18).

PMID: 39337264 PMC: 11432163. DOI: 10.3390/ijms25189775.

Nano-Medicine for Treatment of Tuberculosis, Promising Approaches Against Antimicrobial Resistance.

Mobed A, Alivirdiloo V, Gholami S, Moshari A, Mousavizade A, Naderian R Curr Microbiol. 2024; 81(10):326.

PMID: 39182006 DOI: 10.1007/s00284-024-03853-z.

References

Zhang Y, Wang J, Zhang L . Creation of highly stable selenium nanoparticles capped with hyperbranched polysaccharide in water. Langmuir. 2010; 26(22):17617-23. DOI: 10.1021/la1033959. View

Huang T, Holden J, Heath D, OBrien-Simpson N, OConnor A . Engineering highly effective antimicrobial selenium nanoparticles through control of particle size. Nanoscale. 2019; 11(31):14937-14951. DOI: 10.1039/c9nr04424h. View

Choi S, Britigan B, Moran D, Narayanasamy P . Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages. PLoS One. 2017; 12(5):e0177987. PMC: 5436895. DOI: 10.1371/journal.pone.0177987. View

Wang L, Hu C, Shao L . The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomedicine. 2017; 12:1227-1249. PMC: 5317269. DOI: 10.2147/IJN.S121956. View

Singh R, Nawale L, Arkile M, Shedbalkar U, Wadhwani S, Sarkar D . Chemical and biological metal nanoparticles as antimycobacterial agents: A comparative study. Int J Antimicrob Agents. 2015; 46(2):183-8. DOI: 10.1016/j.ijantimicag.2015.03.014. View

Selim A, Elhaig M, Taha S, Nasr E . Antibacterial activity of silver nanoparticles against field and reference strains of Mycobacterium tuberculosis, Mycobacterium bovis and multiple-drug-resistant tuberculosis strains. Rev Sci Tech. 2019; 37(3):823-830. DOI: 10.20506/rst.37.3.2888. View

Shakibaie M, Forootanfar H, Golkari Y, Mohammadi-Khorsand T, Shakibaie M . Anti-biofilm activity of biogenic selenium nanoparticles and selenium dioxide against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis. J Trace Elem Med Biol. 2014; 29:235-41. DOI: 10.1016/j.jtemb.2014.07.020. View

Tran P, Webster T . Selenium nanoparticles inhibit Staphylococcus aureus growth. Int J Nanomedicine. 2011; 6:1553-8. PMC: 3152473. DOI: 10.2147/IJN.S21729. View

Lu T, Wu Y, Zhao C, Su F, Liu J, Ma Z . One-step fabrication and characterization of FeO/HBPE-DDSA/INH nanoparticles with controlled drug release for treatment of tuberculosis. Mater Sci Eng C Mater Biol Appl. 2018; 93:838-845. DOI: 10.1016/j.msec.2018.08.046. View

10.

Baranwal A, Srivastava A, Kumar P, Bajpai V, Maurya P, Chandra P . Prospects of Nanostructure Materials and Their Composites as Antimicrobial Agents. Front Microbiol. 2018; 9:422. PMC: 5855923. DOI: 10.3389/fmicb.2018.00422. View

11.

Beyth N, Houri-Haddad Y, Domb A, Khan W, Hazan R . Alternative antimicrobial approach: nano-antimicrobial materials. Evid Based Complement Alternat Med. 2015; 2015:246012. PMC: 4378595. DOI: 10.1155/2015/246012. View

12.

Vallet-Regi M, Gonzalez B, Izquierdo-Barba I . Nanomaterials as Promising Alternative in the Infection Treatment. Int J Mol Sci. 2019; 20(15). PMC: 6696612. DOI: 10.3390/ijms20153806. View

13.

Hoseinzadeh E, Makhdoumi P, Taha P, Hossini H, Stelling J, Kamal M . A Review on Nano-Antimicrobials: Metal Nanoparticles, Methods and Mechanisms. Curr Drug Metab. 2016; 18(2):120-128. DOI: 10.2174/1389200217666161201111146. View

14.

Hosnedlova B, Kepinska M, Skalickova S, Fernandez C, Ruttkay-Nedecky B, Peng Q . Nano-selenium and its nanomedicine applications: a critical review. Int J Nanomedicine. 2018; 13:2107-2128. PMC: 5901133. DOI: 10.2147/IJN.S157541. View

15.

Reshma V, Syama S, Sruthi S, Reshma S, Remya N, Valappil Mohanan P . Engineered Nanoparticles with Antimicrobial Property. Curr Drug Metab. 2017; 18(11):1040-1054. DOI: 10.2174/1389200218666170925122201. View

16.

Khan F, Lee J, Pham D, Khan M, Park S, Shin I . Antibiofilm Action of ZnO, SnO and CeO Nanoparticles Towards Grampositive Biofilm Forming Pathogenic Bacteria. Recent Pat Nanotechnol. 2020; 14(3):239-249. DOI: 10.2174/1872210514666200313121953. View

17.

Herman A, Herman A . Nanoparticles as antimicrobial agents: their toxicity and mechanisms of action. J Nanosci Nanotechnol. 2014; 14(1):946-57. DOI: 10.1166/jnn.2014.9054. View

18.

Estevez H, Garcia-Lidon J, Luque-Garcia J, Camara C . Effects of chitosan-stabilized selenium nanoparticles on cell proliferation, apoptosis and cell cycle pattern in HepG2 cells: comparison with other selenospecies. Colloids Surf B Biointerfaces. 2014; 122:184-193. DOI: 10.1016/j.colsurfb.2014.06.062. View

19.

Jafari A, Mosavari N, Movahedzadeh F, Nodooshan S, Safarkar R, Moro R . Bactericidal impact of Ag, ZnO and mixed AgZnO colloidal nanoparticles on HRv Mycobacterium tuberculosis phagocytized by THP-1 cell lines. Microb Pathog. 2017; 110:335-344. DOI: 10.1016/j.micpath.2017.07.010. View

20.

Andreu N, Zelmer A, Fletcher T, Elkington P, Ward T, Ripoll J . Optimisation of bioluminescent reporters for use with mycobacteria. PLoS One. 2010; 5(5):e10777. PMC: 2875389. DOI: 10.1371/journal.pone.0010777. View